Synapse - Colleen Dorsey

Colleen Dorsey

Research Focus

Nursing; Clinical Trials Nurse III

Recent additions – View all

Adding umbralisib and ublituximab (U2) to ibrutinib in patients with CLL: A phase II study of an MRD-driven approach
Journal Article

Roeker, L. E.; Feldman, T. A.; Soumerai, J. D.; Falco, V.; Panton, G.; Dorsey, C.; Zelenetz, A. D.; Falchi, L.; Park, J. H.; Straus, D. J.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save
A phase 2 study evaluating the addition of ublituximab and umbralisib (U2) to ibrutinib in patients with chronic lymphocytic leukemia (CLL): A minimal residual disease (MRD)-driven, time-limited approach
Meeting Abstract

Dorsey, C.; Falco, V.; Pena-Velasquez, C.; Lebowitz, S.; Purdom, M.; Panton, G.
Oncology Nursing Forum (2022)

Fulltext@MSK | Save
Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy
Journal Article

Mato, A. R.; Ghosh, N.; Schuster, S. J.; Lamanna, N.; Pagel, J. M.; Flinn, I. W.; Barrientos, J. C.; Rai, K. R.; Reeves, J. A.; Cheson, B. D.; more...
Blood (2021)

Fulltext@MSK | Save

Co-authors at MSK

9

Mato
8

Zelenetz
6

Roeker
5

Goodfriend
3

Whitaker
2

Battiato
2

Bigelow
2

Falco
2

Geyer
2

King
2

Lebowitz
2

Morse
2

Panton
2

Pena ve...
2

Sarmasti
1

Calivo
1

Deonari...
1

Falchi
1

Fox
1

Kabel
1

Laudati
1

Park
1

Straus
1

Thompson

Types of Work

Publications